[email protected]
CAS 144689-63-4 Olmesartan Medoxomil molecular structure lightbox
CAS RN: 144689-63-4

Olmesartan Medoxomil

Product Availability

Choose a grade to view its available package options.

8 package records8 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250311 100g In stock Shanghai Inquiry
Batchno.20250202 10mg In stock Shanghai Inquiry
Batchno.20251227 1g In stock Shanghai Inquiry
Batchno.20251229 1mg In stock Shanghai Inquiry
Batchno.20260329 25g In stock Shanghai Inquiry
Batchno.20260405 50mg In stock Shanghai Inquiry
Batchno.20250916 5g In stock Shanghai, Shenzhen Inquiry
Batchno.20260306 5mg In stock Shanghai Inquiry
  • Product code: ICTO0510
  • Purity/Analytical Methods: >98.0%(T)(HPLC)
GET A QUOTE

144689-63-4 / (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylate

Standard CAS: 144689-63-4 Multi CAS: No
Basic Information Computed Properties Safety & Transport

Basic Information

CAS
144689-63-4
Multi CAS
No
Molecular Formula
C29H30N6O6
Molecular Weight
558.600000
Exact Mass
558.222683
SMILES
CCCC1=NC(=C(N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)C(=O)OCC5=C(OC(=O)O5)C)C(C)(C)O
InChI
InChI=1S/C29H30N6O6/c1-5-8-23-30-25(29(3,4)38)24(27(36)39-16-22-17(2)40-28(37)41-22)35(23)15-18-11-13-19(14-12-18)20-9-6-7-10-21(20)26-31-33-34-32-26/h6-7,9-14,38H,5,8,15-16H2,1-4H3,(H,31,32,33,34)
InChIKey
UQGKUQLKSCSZGY-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
41
Aromatic heavy atom count
27
Fraction Csp3
0.31
Rotatable bonds
10
H-bond acceptors
11
H-bond donors
2
Molar refractivity
146.72
TPSA
162.16

LogP / Solubility

WLOGP
4.17
MLOGP
3.71
XLogP3
3.8
Consensus LogP
3.89
Log S (ESOL)
-5.76
Class (ESOL)
Slightly soluble
Log S (Ali)
-7.15
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-7.95
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
Low
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
No
CYP2D6 inhibitor
No
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-3.17

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
No
Egan
No
Muegge
No
Bioavailability score
0.17
Leadlikeness
No
Synthetic Accessibility
5

Safety & Transport

Pictogram(s)
Irritant Health Hazard
Signal
Danger
GHS Hazard Statements
H302 (94.8%): Harmful if swallowed [Warning Acute toxicity, oral] H312 (49.1%): Harmful in contact with skin [Warning Acute toxicity, dermal] H319 (46.6%): Causes serious eye irritation [Warning Serious eye damage/eye irritation] H332 (49.1%): Harmful if inhaled [Warning Acute toxicity, inhalation] H360 (46.6%): May damage fertility or the unborn child [Danger Reproductive toxicity]
Precautionary Statement Codes
P203, P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P318, P321, P330, P337+P317, P362+P364, P405, and P501

Customers Also Viewed

Get In Touch

Contact Us